Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer

NCT04540692 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

444

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel or Paclitaxel
DRUG: Cyclophosphamide + Doxorrubicin

Sponsor

Latin American Cooperative Oncology Group

Collaborators

[object Object]